Dimensional Fund Advisors LP Vertex Pharmaceuticals Inc Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 647,808 shares of VRTX stock, worth $259 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

647,808

Previous 662,957 2.29%

Holding current value

$259 Million

Previous $311 Million 3.04%

% of portfolio

0.07%

Previous 0.08%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$460.0 - $505.78 $6.97 Million - $7.66 Million	-15,149 Reduced 2.29%	647,808 $301 Million
Q2 2024 Aug 09, 2024	BUY	$392.81 - $485.53 $29.5 Million - $36.4 Million	75,045 Added 12.76%	662,957 $311 Million
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $1.1 Million - $1.2 Million	2,696 Added 0.46%	587,912 $246 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $2.46 Million - $2.95 Million	-7,179 Reduced 1.21%	585,216 $238 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $6.19 Million - $6.63 Million	-18,304 Reduced 3.0%	592,395 $206 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $3.18 Million - $3.56 Million	-10,116 Reduced 1.63%	610,699 $215 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $45.2 Million - $51.6 Million	-159,687 Reduced 20.46%	620,815 $196 Million
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $23.9 Million - $26.9 Million	-83,805 Reduced 9.7%	780,502 $225 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $4.75 Million - $5.3 Million	-17,338 Reduced 1.97%	864,307 $250 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $16.8 Million - $20.9 Million	-71,529 Reduced 7.5%	881,645 $248 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $4.24 Million - $5 Million	19,141 Added 2.05%	953,174 $249 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $40.6 Million - $51.3 Million	229,487 Added 32.57%	934,033 $205 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $33.7 Million - $37.7 Million	185,523 Added 35.74%	704,546 $128 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $9.26 Million - $10.9 Million	49,412 Added 10.52%	519,023 $105 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $3.12 Million - $3.63 Million	15,062 Added 3.31%	469,611 $101 Million
Q4 2020 Feb 25, 2021	BUY	$207.01 - $276.09 $94.1 Million - $125 Million	454,549 New	454,549 $107 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Vertex Pharmaceuticals Inc Transaction History